# Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer

> **NCT02459912** · PHASE2 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 1 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** Unilateral Nerve-Sparing Cryoablation of the Prostate
- **DEVICE:** Precise Cryoablation System with IceRod Needles

## Key facts

- **NCT ID:** NCT02459912
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2018-04-26
- **Final completion:** 2018-04-26
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Patient recruitment
- **Last updated:** 2019-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02459912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02459912, "Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02459912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*